Shelter Pharma Limited has announced strategic appointments across its sales and export divisions to strengthen its organizational structure and support business expansion plans. The appointments were disclosed to BSE Limited under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Senior Management Appointments

The company has made key appointments at the senior management level to enhance its sales operations. Mr. Javed has been appointed as Zonal Sales Manager (ZSM) for the Veterinary Division, while Mr. Ashok Chauhan joins as Regional Sales Manager (RSM) for Uttarakhand and Western Uttar Pradesh.

Field Sales Team Expansion

Shelter Pharma has strengthened its field force by appointing three Sales Officers across strategic locations in Gujarat and Rajasthan. These appointments are designed to enhance market penetration and improve regional coverage.

Role Responsibilities and Structure

The Zonal Sales Manager will be responsible for managing a defined zone covering multiple states, overseeing Regional Sales Managers, driving sales performance, undertaking sales analysis, and formulating strategic initiatives aligned with the company's objectives. The role operates in close coordination with the Head Office.

The Regional Sales Manager will handle regional sales operations, lead field teams, ensure achievement of sales targets, and execute strategies at the ground level. The RSM reports directly to the ZSM, creating a clear hierarchical structure.

Export Operations Enhancement

To support its international business development, the company has appointed Mr. Saumil Ghaghada as Export Executive at the Head Office. This appointment is aimed at enhancing export operations and expanding the company's presence in international markets.

Strategic Impact

These appointments reflect Shelter Pharma's continued focus on strengthening its sales hierarchy, improving operational efficiency, enhancing market penetration, and expanding its presence in both domestic and international markets. The strategic strengthening of the sales and export organizational structure is expected to support the company's business growth objectives across multiple regions.

Shelter Pharma Limited has officially communicated to BSE Limited regarding the non-applicability of certain regulatory compliance requirements for SME-listed entities. The company has clarified its exemption status from Annual Secretarial Compliance report under Regulation 24A of SEBI regulations.

Regulatory Exemption Details

The company has informed BSE that as an entity listed on the BSE SME Platform, it is exempt from compliance with multiple SEBI regulations. According to Regulation 15(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, SME-listed entities are not required to comply with specific regulatory provisions.

Scope of Regulatory Exemptions

The exemptions cover a comprehensive range of SEBI regulations for SME-listed entities. These include regulations related to corporate governance, board composition, and compliance reporting requirements that typically apply to main board listed companies.

The specific regulations from which the company is exempt include:

• Regulations 17, 17A, 18, 19, 20, 21, 22, 24, 24A, 25, 26, 27
• Clause (b) to (i) of sub regulation (2) of Regulation 46
• Para C, D, F and E of Schedule V of SEBI LODR Regulations

Official Communication

The formal communication was submitted to BSE Limited at Floor 25, P J Towers, Dalal Street, Mumbai. The letter was digitally signed by Mustaqim Nisarahmed Sabugar, Managing Director of the company, bearing DIN: 01456841.

The company has requested BSE to take this information on record, confirming its understanding and compliance with the applicable regulatory framework for SME-listed entities. This communication ensures transparency regarding the company's regulatory obligations and exemptions under the current SEBI framework for SME platforms.